Monocyte activation test market was estimated to be over US$ 6.63 million in 2018. It is anticipated to grow at a CAGR of 13.3% from 2019 to 2030.
There are several advantages of monocyte activation test which increases its application over the other pyrogen testing available. The advantages of MAT includes high efficiency of detection of both endotoxin & non-endotoxin contaminants, accurate analyses of pyrogenic activity in complex pharmaceuticals such as blood-derived products, cell-derived products, biologics and vaccines. Moreover, the shift in regulatory approvals in several regions is favouring the adoption of monocyte activation test over animal based tests such as Rabbit Pyrogen test (RPT). For instance, in the year 2010, a chapter on MAT was introduced in the European Pharmacopeia as an alternative to the Rabbit Pyrogen test wherever possible. Similarly, in Japan, a general notice was included in the JP XVII edition, which indicated the application of MAT for diagnostic purposes due to its better accuracy & precision.
Major Key Players of the Monocyte Activation Test Market are:Merck, Thermo Fisher Scientific, Becton, Dickinson and Company, Sanquin, Charles River Laboratories International, Inc., Microcoat Biotechnologie GmbH, SOLVIAS AG and Lonza Group among others.
Read More @ https://www.openpr.com/news/2020093/monocyte-activation-test-market-exploring-future-growth
There are several advantages of monocyte activation test which increases its application over the other pyrogen testing available. The advantages of MAT includes high efficiency of detection of both endotoxin & non-endotoxin contaminants, accurate analyses of pyrogenic activity in complex pharmaceuticals such as blood-derived products, cell-derived products, biologics and vaccines. Moreover, the shift in regulatory approvals in several regions is favouring the adoption of monocyte activation test over animal based tests such as Rabbit Pyrogen test (RPT). For instance, in the year 2010, a chapter on MAT was introduced in the European Pharmacopeia as an alternative to the Rabbit Pyrogen test wherever possible. Similarly, in Japan, a general notice was included in the JP XVII edition, which indicated the application of MAT for diagnostic purposes due to its better accuracy & precision.
Major Key Players of the Monocyte Activation Test Market are:Merck, Thermo Fisher Scientific, Becton, Dickinson and Company, Sanquin, Charles River Laboratories International, Inc., Microcoat Biotechnologie GmbH, SOLVIAS AG and Lonza Group among others.
Read More @ https://www.openpr.com/news/2020093/monocyte-activation-test-market-exploring-future-growth
No comments:
Post a Comment